68 Biggest Movers From Wednesday
26 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
Mid-Afternoon Market Update: Dow Falls 75 Points; Biofrontera Shares Spike Higher
24 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Wednesday, the Dow traded down 0.21% to 35,738.42 while the NASDAQ rose 0.06% to 15,784.86. The S&P also rose, gaining 0.01% to 4,690.76.
Mid-Day Market Update: Gap Drops Following Downbeat Q3 Results; Ocuphire Pharma Shares Jump
24 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets
Midway through trading Wednesday, the Dow traded down 0.28% to 35,714.19 while the NASDAQ fell 0.29% to 15,729.96. The S&P also fell, dropping 0.20% to 4,681.42.
40 Stocks Moving In Wednesday's Mid-Day Session
24 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
HC Wainwright & Co. Initiates Coverage On Ocuphire Pharma with Buy Rating, Announces Price Target of $26
24 Nov 21
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. analyst Andrew Fein initiates coverage on Ocuphire Pharma (NASDAQ:OCUP) with a Buy rating and announces Price Target of $26.
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
12 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Small Cap, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
8 Nov 21
Biotech, Earnings, News, Penny Stocks, Small Cap, IPOs, Top Stories, General
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week.
Ocuphire Announces Publications Featuring The Ref-1 Protein, A Transcription Factor Regulator, As A Novel Therapeutic Target For The Treatment Of Neovascular Retinal Diseases
7 Oct 21
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for refractive and retinal eye disorders, today announced the publication of
Ocuphire Pharma To Present Data On Phase 2b Trial For APX3330 For Retina At Ophthalmology Innovation Summit Retina@ASRS Innovation Company Showcase Oct. 7 At 10:16 a.m. EDT, Diabetic Symposium Oct. 9 9:51 a.m. EDT
1 Oct 21
Biotech, News, FDA, Events, General
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that its